Bio-Rad Laboratories (BIO) EBT Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Bio-Rad Laboratories (BIO) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 30.00 |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 617.00 |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 258.00 |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -646.00 |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | -82.00 |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 2,922.00 |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 1,974.00 |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | -305.00 |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | -3,374.00 |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | -683.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1,974.00 |
| Mar 31, 2026 | -13,075.00 |
| Dec 31, 2025 | 27,021.00 |
| Sep 30, 2025 | -19,863.00 |
| Jun 30, 2025 | 49,992.00 |
| Mar 31, 2025 | -6,616.00 |
| Dec 31, 2024 | -19,905.00 |
| Sep 30, 2024 | 11,093.00 |
| Jun 30, 2024 | -21,609.00 |
| Mar 31, 2024 | 6,787.00 |
| Dec 31, 2023 | -8,656.00 |
| Sep 30, 2023 | 5,214.00 |
| Jun 30, 2023 | -4,373.00 |
| Mar 31, 2023 | 63,645.00 |
| Dec 31, 2022 | 42,607.00 |
| Sep 30, 2022 | -70,277.00 |
| Jun 30, 2022 | -33,815.00 |
| Mar 31, 2022 | -80,240.00 |
| Dec 31, 2021 | -41,450.00 |
| Sep 30, 2021 | 41,208.00 |